The recombinant protein vaccine, dubbed GSK3943104, did not meet the study’s primary efficacy objective. GSK added that the ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

Learn about our Editorial Policies. The researchers first tested how their OspA mRNA vaccine affected cells of the adaptive immune system by isolating immune cells from mice immunized with OspA mRNA, ...

It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States ...

The effective transmission of viral particles from cell-to-cell depends heavily on the A33R protein. It is a possible target for the creation of diagnostic tests, vaccines, and drugs. Recombinant ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...